Searched over 200M research papers
10 papers analyzed
These studies suggest that non-prescription diabetes medications are commonly used but often not in line with guidelines, with adherence influenced by various demographic and systemic factors.
20 papers analyzed
Non-prescription diabetes medications, also known as over-the-counter (OTC) diabetes treatments, are limited in availability and efficacy compared to prescription medications. However, understanding the trends and factors influencing the use of non-prescription and prescription diabetes medications can provide insights into patient adherence, treatment efficacy, and healthcare practices.
Studies have shown that metformin is the most commonly prescribed initial oral antidiabetic agent for patients with newly diagnosed type 2 diabetes (T2D) . Despite this, there are significant variations in prescription practices based on patient demographics, physician characteristics, and healthcare facility types. For instance, male patients and older individuals are more likely to receive non-metformin prescriptions. Additionally, metformin is less frequently prescribed in for-profit hospitals and rural areas.
Research indicates that the prescribing of non-insulin diabetes medications often deviates from clinical guidelines, particularly in patients with renal impairment. Metformin, DPP4 inhibitors, and sulphonylureas are frequently prescribed at doses inconsistent with current guidelines, which can lead to suboptimal treatment outcomes. This highlights the need for better dissemination and adherence to clinical guidelines among healthcare providers.
Non-adherence to non-insulin glucose-lowering drugs is a significant issue, with approximately one-third of patients not adhering to their prescribed medications. Factors contributing to non-adherence include non-Spanish nationality, current employment, low adherence to previous medications, smoking, and absence of hypertension. Additionally, higher dosing frequency and preprandial administration are associated with lower adherence rates.
Non-adherence to diabetes medications adversely affects glycemic control and increases the likelihood of insulin initiation. Adherent patients tend to have lower HbA1c levels and are less likely to require insulin therapy, underscoring the importance of adherence for effective diabetes management.
Even after initiating insulin therapy, many patients continue to use non-insulin diabetes medications. Metformin remains the most commonly continued medication, followed by SGLT2 inhibitors and TZDs. However, the continuation rates for other medications like sulfonylureas are lower, indicating variability in treatment practices.
Interventions such as pharmacy-based value-added utilities, including medication refill reminders and unit-of-use packaging, have been shown to improve prescription refill compliance and reduce healthcare expenditures. However, low-intensity interventions like scripted telephone calls from diabetes educators have not significantly improved medication adherence or metabolic control.
Efforts to improve medication adherence should consider socio-demographic and clinical factors that influence patient behavior. Tailored interventions that address specific barriers to adherence, such as simplifying dosing regimens and providing education on the importance of medication adherence, may be more effective.
Non-prescription diabetes medications play a limited role in diabetes management compared to prescription medications. Understanding the trends, adherence issues, and factors influencing the use of diabetes medications can help healthcare providers optimize treatment strategies and improve patient outcomes. Continued research and targeted interventions are essential to enhance adherence and ensure effective diabetes management.
Most relevant research papers on this topic